Jay D. Rosenbaum’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-7,502
| Closed | -$519K | – | 66 |
|
|
2023
Q2 | $519K | Sell |
7,502
-1,880
| -20% | -$134K | 0.83% | 42 |
|
|
2023
Q1 | $697K | Buy |
9,382
+931
| +11% | +$78.1K | 1.28% | 36 |
|
|
2022
Q4 | $788K | Buy |
8,451
+415
| +5% | +$40K | 1.7% | 24 |
|
|
2022
Q3 | $766K | Sell |
8,036
-124
| -2% | -$12.3K | 1.77% | 20 |
|
|
2022
Q2 | $756K | Sell |
8,160
-154
| -2% | -$15K | 1.46% | 31 |
|
|
2022
Q1 | $841K | Buy |
8,314
+206
| +3% | +$21.6K | 1.33% | 30 |
|
|
2021
Q4 | $836K | Sell |
8,108
-2,066
| -20% | -$191K | 1.23% | 32 |
|
|
2021
Q3 | $864K | Sell |
10,174
-1,473
| -13% | -$123K | 1.44% | 29 |
|
|
2021
Q2 | $971K | Buy |
11,647
+3,392
| +41% | +$278K | 1.61% | 28 |
|
|
2021
Q1 | $621K | Buy |
8,255
+545
| +7% | +$39.7K | 1.06% | 39 |
|
|
2020
Q4 | $526K | Sell |
7,710
-10
| -0.1% | -$650 | 0.91% | 43 |
|
|
2020
Q3 | $451K | Sell |
7,720
-355
| -4% | -$22.1K | 0.83% | 43 |
|
|
2020
Q2 | $524K | Buy |
8,075
+400
| +5% | +$25.2K | 1.03% | 37 |
|
|
2020
Q1 | $455K | Sell |
7,675
-1,977
| -20% | -$132K | 1.05% | 39 |
|
|
2019
Q4 | $717K | Sell |
9,652
-3,908
| -29% | -$274K | 1.27% | 35 |
|
|
2019
Q3 | $856K | Sell |
13,560
-200
| -1% | -$11.9K | 1.63% | 28 |
|
|
2019
Q2 | $751K | Buy |
13,760
+50
| +0.4% | +$2.69K | 1.42% | 31 |
|
|
2019
Q1 | $740K | Buy |
13,710
+185
| +1% | +$11.4K | 1.4% | 27 |
|
|
2018
Q4 | $886K | Sell |
13,525
-1,250
| -8% | -$93.3K | 1.88% | 24 |
|
|
2018
Q3 | $1.16M | Sell |
14,775
-1,535
| -9% | -$110K | 2.11% | 20 |
|
|
2018
Q2 | $1.05M | Buy |
16,310
+990
| +6% | +$65.2K | 2.08% | 22 |
|
|
2018
Q1 | $953K | Sell |
15,320
-2,000
| -12% | -$143K | 1.92% | 27 |
|
|
2017
Q4 | $1.26M | Buy |
17,320
+40
| +0.2% | +$2.91K | 2.31% | 19 |
|
|
2017
Q3 | $1.41M | Buy |
17,280
+700
| +4% | +$55.4K | 2.69% | 14 |
|
|
2017
Q2 | $1.33M | Buy |
16,580
+700
| +4% | +$55.3K | 2.64% | 14 |
|
|
2017
Q1 | $1.25M | Buy |
15,880
+1,300
| +9% | +$104K | 2.64% | 16 |
|
|
2016
Q4 | $1.15M | Buy |
14,580
+925
| +7% | +$74.8K | 2.67% | 15 |
|
|
2016
Q3 | $1.22M | Buy |
13,655
+2,055
| +18% | +$194K | 0.15% | 17 |
|
|
2016
Q2 | $1.11M | Buy |
11,600
+2,985
| +35% | +$297K | 0.16% | 17 |
|
|
2016
Q1 | $893K | Buy |
8,615
+1,065
| +14% | +$104K | 0.2% | 22 |
|
|
2015
Q4 | $738K | Hold |
7,550
| – | – | 0.21% | 22 |
|
|
2015
Q3 | $728K | Hold |
7,550
| – | – | 0.21% | 23 |
|
|
2015
Q2 | $791K | Hold |
7,550
| – | – | 0.18% | 23 |
|
|
2015
Q1 | $779K | Buy |
7,550
+25
| +0.3% | +$2.53K | 0.17% | 23 |
|
|
2014
Q4 | $725K | Buy |
+7,525
| New | +$663K | 0.16% | 23 |
|
Other funds holding CVS
Jay D. Rosenbaum's CVS Position: Q3 2023 in Review
Jay D. Rosenbaum sold out of CVS Health (CVS) in Q3 2023, closing a stake of 7,502 shares — an estimated $519K sold.
Jay D. Rosenbaum first reported a position in CVS in Q4 2014 and held it in 35 quarters. The position peaked at $1.41M in Q3 2017. 2,114 funds tracked by Wall St. Rank hold CVS as of Q3 2023.
- Jay D. Rosenbaum reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
- Jay D. Rosenbaum sold 7,502 CVS Health shares in Q3 2023, an estimated $519K.
- Jay D. Rosenbaum first reported a position in CVS Health in Q4 2014 and held it in 35 quarters.
- Jay D. Rosenbaum's CVS Health position peaked at $1.41M in Q3 2017.
- 2,114 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.
Based on Jay D. Rosenbaum's 13F filing for Q3 2023, filed 23 Oct 2023.